ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 379399 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 379399; 2) Community: the network communities that were significantly associated with the response to NSC 379399; 3) Molecule: the relationships between components within communities and NSC 379399; 4) MDR: the compounds that were significantly associated with the NSC 379399.

NSC Compound Enrichment Correlation
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.00888636978630782 0.45535485
NSC 748707 Null 0.00888636978630782 0.31575771
NSC 93135 OXYACANTHINE 0.00888636978630782 0.20767199
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0102077332082016 -0.018990443
NSC 618487 STAUROSPORINE 0.0102077332082017 -0.14091936
NSC 676498 TP4EK-K6 0.0102077332082017 -0.50117403
NSC 732490 Null 0.0102077332082017 0.12668206
NSC 735334 Null 0.0102077332082017 0.096080115
NSC 740275 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0102077332082017 0.10730473
NSC 628564 Null 0.0102962192514438 0.13905966
Total:64  Current:13    [First] [Prev] [Next] [Last]